If you liked this article you might like

Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics
Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments
Rev's Forum: News Flow Works Against the Bears Once More
Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows